Pan-resistant acinetobacter baumannii mediastinitis treated successfully with tigecycline: A case report

Surgical Infections

Volumn 12, Issue 2, 2011, Pages 141-143

  Tekçe, Ayşe Yasemin Tezer ^a   Erbay, Ayşe ^a   Çabadak, Hatice ^a   Yaǧci, Serap ^a   Karabiber, Nihal ^a   Şen, Süha ^a  

^a TURKIYE YUKSEK IHTISAS HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE DERIVATIVE; BETA LACTAM DERIVATIVE; CILASTATIN PLUS IMIPENEM; COLISTIN; COTRIMOXAZOLE; QUINOLONE DERIVATIVE; TEICOPLANIN; TETRACYCLINE; TIGECYCLINE;

ACINETOBACTER BAUMANNII; ADULT; ANAMNESIS; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM CULTURE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; LABORATORY TEST; LOADING DRUG DOSE; MEDIASTINITIS; PRIORITY JOURNAL; WOUND CARE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; CARDIOPULMONARY BYPASS; DEBRIDEMENT; DRAINAGE; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HUMANS; MEDIASTINITIS; MIDDLE AGED; MINOCYCLINE; SURGICAL WOUND INFECTION; TREATMENT OUTCOME;

EID: 79955771685     PISSN: 10962964     EISSN: None     Source Type: Journal    
DOI: 10.1089/sur.2009.063     Document Type: Article

References (12)

1. Sunenshine RH, Wright MO, Maragakis LL, et al. Multidrugresistant Acinetobacter infection mortality rate and length of hospitalization. Emerg Infect Dis 2007;13:97-103. (Pubitemid 46057843)
2. Li J, Nation RL, Owen RJ, et al. Antibiograms of multidrugresistant clinical Acinetobacter baumannii: Promising therapeutic options for treatment of infection with colistin-resistant strains. Clin Infect Dis 2007;45:594-598. (Pubitemid 47328640)
3. Vila J, Pachón J. Therapeutic options for Acinetobacter baumannii infections. Expert Opin Pharmacother 2008;9:587-599. (Pubitemid 351425386)
4. Merrill WH, Akhter SA, Wolf RK, et al. Simplified treatment of postoperative mediastinitis. Ann Thorac Surg 2004;78: 608-612. (Pubitemid 38980784)
5. Abid Q, Nkere UU, Hasan A, et al. Mediastinitis in heart and lung transplantation: 15 years experience. Ann Thorac Surg 2003;75:1565-1571. (Pubitemid 36515241)
6. Lachanas E, Tomos P, Sfyras N, et al. Acinetobacter baumannii mediastinitis after cardiopulmonary bypass: Case report and literature review. Surg Infect (Larchmt) 2008;9:201-204. (Pubitemid 351563816)
7. George RS, Birks EJ, Haj-Yahia S, et al. Acinetobacter mediastinitis in a heart transplant patient. Ann Thorac Surg 2006;82:715-716. (Pubitemid 44079998)
8. Giamarellou H, Antoniadou A, Kanellakopoulou K. Acinetobacter baumannii: A universal threat to public health? Int J Antimicrob Agents 2008;32:106-119.
9. Garrison MW, Mutters R, Dowzicky MJ. In vitro activity of tigecycline and comparator agents against a global collection of gram negative and gram positive organisms: Tigecycline evaluation and surveillance trial 2004 to 2007. Diagn Microbiol Infect Dis 2009;65:288-299.
10. Casal M, Rodriguez F, Johnson B, et al. Influence of testing methodology on the tigecycline activity profile against presumably tigecycline non-susceptible Acinetobacter spp. J Antimicrob Chemother 2009;64:69-72.
11. Schein M, Marshall J. Source control for surgical infections. World J Surg 2004;28:638-645. (Pubitemid 39097117)
12. Anthony KB, Fishman NO, Linkin DR, et al. Clinical and microbiological outcomes of serious infections with multidrug-resistant gram-negative organisms treated with tigecycline. Clin Infect Dis 2008;46:567-570. (Pubitemid 351263497)